International experts renew calls for registration of clinical trials
Main Category: Pharma Industry / Biotech IndustryArticle Date: 23 Apr 2005 - 0:00 PDT
A group of 80 international experts is calling for the public registration of all clinical trials. The Ottawa Statement, the result of an open meeting hosted by the Canadian Institutes of Health Research (CIHR) in October 2004, was published today in the British Medical Journal (BMJ).
"Publicly registering clinical trials will lead to the sharing of new knowledge that will accelerate the development of safer, more effective treatments," said Alan Bernstein, President of CIHR. "Consensus that public disclosure is a necessary ingredient of ethical clinical research is growing and CIHR's decision last summer to register the randomized controlled trials it funds is contributing to this momentum."
"Health Canada will continue to move toward greater transparency and awareness of information on clinical trials - I want Canadians to have access to the good, the bad and the ugly," said the Hon. Ujjal Dosanjh Minister of Health. "The World Health Organization has recently launched a process to develop a global approach to clinical trial registration and Health Canada and CIHR will be contributing to this process."
Sally Brown, Steering Committee Member of the Health Charities Council of Canada (HCCC) shared the support of national health charities and applauded the leadership of the Canadian research community to registration of clinical trials. "HCCC strongly supports the efforts of the Government of Canada to make the clinical trials process more transparent for the benefit of Canadians participating in trials and, indeed, for all Canadians," said Sally Brown.
The registration of clinical trials has been of long-time interest to the research community. Widespread media coverage last spring of reports linking suicide to the use of anti-depressants in children highlighted the need for early public access to evidence obtained through clinical trials.
The Ottawa Statement outlines three key principles for registration to help ensure clinicians, researchers, patients and the public have access to information about clinical trials. These principles are:
1 Registering all types of trials - Protocol information and results from all trials related to health or healthcare - regardless of topic, design, outcomes, or market status of interventions examined - should be registered and publicly available;
2 Timing of public release of protocol information - The public should have cost-free access to each trial's unique ID, minimum protocol items, and consent forms prior to participant enrolment. Registered amendments should be made publicly available as they occur;
3 Registering unpublished results - At a minimum, results for outcomes and analyses specified in the protocol (as approved by the main institutional review board/independent ethics committee), as well as any data on harms, should be registered regardless of whether or not they are published.
"The Ottawa Statement on clinical trial registration is already having an impact," says Dr. Karmela Krleza-Jeric, co-author of the Ottawa Statement and CIHR clinical research officer, referring to a group assembled by the World Health Organization that has used the Ottawa Statement to guide its development of global trial registration protocols, "In the coming year, we will continue to work together to define the most effective and practical ways to put these principles into action throughout the world."
In July 2004, CIHR began registering all randomized controlled trials it funds. In September, many of the world's major medical journals decided only to publish results of registered clinical trials.
About CIHR
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. Composed of 13 Institutes, CIHR provides leadership and support to almost 10,000 researchers and research teams in every province of Canada.
For additional information contact:
Janet Weichel McKenzie
Canadian Institutes of Health Research
613 941-4563 wk 613-447-4794 cell
jweichel@cihr-irsc.gc.ca
Adčle Blanchard
Office of Minister Dosanjh
(613) 957-0200
Health Canada
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/23315.php>
APA
http://www.medicalnewstoday.com/releases/23315.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
A start, but not enough
posted by sam bryks on 24 Apr 2005 at 6:30 pmA recent article in the New York Times (April 24,2005) revealed how the manufacturer of Vioxx was "hedging" on reporting a death of a patient in a clinicial trial caused by a likely heart attack. There has also been a tendency for some practitioners to minimize risks (such as in the case of the SSRI's) for fear that statistically "small" risks may discourage patients from accepting a drug. The horror reality is when the small risk becomes a possible contributing factor to the loss of a family member due to suicide, there is a tendency to blame the existing condition of depression and exclude the drug as a major contributory factor. There is a great need to educate physicians and to ensure that they pay heed to risk factors and advise patients and family members. A statistic is faceless and cold and neutral - even moreso than a tragic story on the news that we hear and thank providence it is not us, but the loss of a beloved family member from a side effect of a drug or increased risk due to poor information and lack of awareness destroys people.
It like an industrial accident in which a young person was not advised of risk, and it cost them their life.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



